<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01016613</url>
  </required_header>
  <id_info>
    <org_study_id>P30DK081943</org_study_id>
    <secondary_id>P30DK081943</secondary_id>
    <nct_id>NCT01016613</nct_id>
  </id_info>
  <brief_title>Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center</brief_title>
  <acronym>C-PROBE</acronym>
  <official_title>Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. John Health System, Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>John H. Stroger Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Levine Childrenâ€™s Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic kidney disease (CKD) affects approximately 26 million Americans and
      disproportionately manifests in specific race and ethnic groups. Patients burdened with CKD
      have significant morbidity and reduced life expectancy. In addition to excessive suffering
      and lost productivity, the cost of managing this epidemic has reached $40 billion annually.
      The recognition that CKD is a major public health problem is reflected in the fourteen
      objectives outlined in Healthy People 2020 to begin to address the disease burden.
      Advancement in approaches to halt CKD progression has been slow despite growing global
      awareness of disease burden.

      This O'Brien Kidney Research Core will create opportunities for novel insights through
      characterization of tissue profiles that will define new disease markers and molecular
      pathways and will be available to all kidney investigators on the www. It will thereby
      fundamentally alter the starting point for research into prevention of progression of these
      kidney diseases. C-PROBE is an essential element of the center grant and presents a
      biomedical resource core consisting of: (1) clinical phenotyping (that is, systematic
      identification of observable physical and biomedical characteristics) of kidney disease
      patients including the accurate measurement of kidney function; and (2) a specimen BioBank
      which will store blood, urine and kidney tissue samples. A key component of C-PROBE is
      therefore that it contains a proven mechanism to collect samples from high risk groups
      including minorities, at the institutions of University of Michigan Health System, St. John
      Hospital, Wayne State University in Michigan, John H. Stroger Hospital in Illinois, Temple
      University Health System in Pennsylvania, and Levine Children's Hospital in North Carolina.
      This mechanism will feed the other Cores and provide biomedical investigators with approved
      projects the access to a dynamic pool of well characterized high risk kidney disease patients
      and their biological specimens to conduct high caliber translational research.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">July 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">1620</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <condition>Glomerulopathy</condition>
  <arm_group>
    <arm_group_label>Chronic Kidney Disease Cohort</arm_group_label>
    <description>chronic kidney disease patients with any type of kidney disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Matched Control Group</arm_group_label>
    <description>Healthy controls</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Trios</arm_group_label>
    <description>First degree relatives of pediatric chronic kidney disease cohort members</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Urine, blood and renal tissue, if available
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Nephrology clinic patients and community members
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  persons of any age who have chronic kidney disease (abnormally high protein in urine
             or reduced kidney function determined by blood tests)

          -  a small number of people without chronic kidney disease

        Exclusion Criteria:

          -  people on hemodialysis or peritoneal dialysis

          -  people who have had a kidney transplant

          -  people unable or unwilling to provide consent

          -  women who are pregnant or nursing

          -  adults who have polycystic kidney disease

          -  institutionalized persons

          -  people currently participating in a blinded interventional clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Subramanium Pennathur, MBBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Crystal A Gadegbeku, MD</last_name>
    <role>Study Director</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Matthias Kretzler, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Debbie Gipson, MD, MS</last_name>
    <role>Study Director</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer J Hawkins, MPH</last_name>
    <phone>734-615-8304</phone>
    <email>jenjoyce@med.umich.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Debbie Gipson, MD, MS</last_name>
    <phone>734-232-4830</phone>
    <email>dgipson@med.umich.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>John H. Stroger Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Taha Iqbal, MD</last_name>
      <phone>312-864-4614</phone>
      <email>tiqbal@cookcountyhhs.org</email>
    </contact>
    <contact_backup>
      <last_name>Kalyani Perumal, MD</last_name>
      <phone>312-864-4601</phone>
      <email>kperumal@ccbhs.org</email>
    </contact_backup>
    <investigator>
      <last_name>Kalyani Perumal, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Michigan Health System</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer J Hawkins, MPH</last_name>
      <phone>734-615-8304</phone>
      <email>jenjoyce@med.umich.edu</email>
    </contact>
    <contact_backup>
      <last_name>Sana Shaikh, MD</last_name>
      <phone>734-736-4273</phone>
      <email>skazi@med.umich.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Subramaniam Pennathur, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Debbie Gipson, MD, MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wayne State University</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joe Chue, BS</last_name>
      <phone>313-745-2378</phone>
      <email>eh0486@wayne.edu</email>
    </contact>
    <contact_backup>
      <last_name>Zeenat Bhat, MD</last_name>
      <phone>313-745-7145</phone>
      <email>eb4887@wayne.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Zeenat Bhat, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. John's Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48236</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sherry Gasko, RN, BSN</last_name>
      <phone>313-886-8787</phone>
      <phone_ext>1264</phone_ext>
      <email>sgasko@scsp.net</email>
    </contact>
    <contact_backup>
      <last_name>Teresa Kozlowski</last_name>
      <phone>313-886-8787</phone>
      <phone_ext>1218</phone_ext>
      <email>tkozlowski@scsp.net</email>
    </contact_backup>
    <investigator>
      <last_name>Keith Bellovich, DO</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Levine Children's Hospital</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kendra Titus</last_name>
      <phone>704-347-2273</phone>
      <email>Kendra.Titus@carolinashealthcare.org</email>
    </contact>
    <contact_backup>
      <last_name>Susan Massengill, MD</last_name>
      <phone>704-381-8800</phone>
      <email>Susan.Massengill@carolinashealthcare.org</email>
    </contact_backup>
    <investigator>
      <last_name>Susan Massengill, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zoe Pfeffer</last_name>
      <phone>201-707-4712</phone>
      <email>zoe.pfeffer@temple.edu</email>
    </contact>
    <contact_backup>
      <last_name>Crystal A Gadegbeku, MD</last_name>
      <phone>215-707-0744</phone>
      <email>Crystal.Gadegbeku@tuhs.temple.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Crystal A Gadegbeku, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2009</study_first_submitted>
  <study_first_submitted_qc>November 18, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2009</study_first_posted>
  <last_update_submitted>June 2, 2017</last_update_submitted>
  <last_update_submitted_qc>June 2, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Debbie Gipson, MD</investigator_full_name>
    <investigator_title>Professor of Pediatrics and Communicable Diseases</investigator_title>
  </responsible_party>
  <keyword>chronic kidney disease</keyword>
  <keyword>glomerulonephritis</keyword>
  <keyword>proteinuria</keyword>
  <keyword>nephrotic syndrome</keyword>
  <keyword>nephropathy</keyword>
  <keyword>biobank</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

